Journal of Dental Research, Vol 78, 1245-1250, Copyright © 1999 by International & American Associations for Dental Research Online Journals

ARTICLES

The effects of histatin-derived basic antimicrobial peptides on oral biofilms

E. J. Helmerhorst, R. Hodgson, W. van 't Hof, E. C. Veerman, C. Allison and A. V. Nieuw Amerongen
Academic Centre for Dentistry (ACTA), Vrije Universiteit, Department of Oral Biochemistry, The Netherlands.

Susceptibility of bacteria to antimicrobial agents is strongly reduced by the formation of complex biofilms. We investigated whether synthetic histatin analogs with broad-spectrum antibacterial activity in vitro were also active against these complex mixtures of bacteria, as present in saliva and plaque. In a simplified model system for dental plaque, hydroxyapatite discs were placed in a continuous culture system comprised of Streptococcus mutans, S. sanguis, S. salivarius, Actinomyces naeslundii, Veillonella parvula, Fusobacterium nucleatum, and Prevotella intermedia. Ex situ treatment of the biofilms formed on these discs with 100 microg/mL of peptide dhvar4 significantly reduced facultative anaerobic, total anaerobic, and obligate anaerobic Gram-negative counts with 0.8, 0.5, and 0.5 log units, respectively. Ex vivo treatment of salivary bacteria gave reductions of 0.4, 0.7, and 1.5 log units, respectively. For ex vivo treatment of plaque bacteria, reductions of 0.4, 0.4, and 1.4 log units, respectively, were found. In both saliva and plaque samples, obligate anaerobic Gram-negative bacteria were significantly more susceptible to dhvar4 than facultatively anaerobic or anaerobic bacteria as a whole (p=0.013 and p=0.018, for salivary bacteria, and p=0.021 and p=0.020 for plaque bacteria, respectively). Although the oral bacteria are protected by biofilm formation, the synthetic histatin analog caused a significant reduction of viable counts in a model for oral biofilm as well as in isolated oral biofilms.

This article has been cited by other articles:

				H. Altman, D. Steinberg, Y. Porat, A. Mor, D. Fridman, M. Friedman, and G. Bachrach In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria J. Antimicrob. Chemother., July 1, 2006; 58(1): 198 - 201. [Abstract] [Full Text] [PDF]

				G.-X. Wei, A. N. Campagna, and L. A. Bobek Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm J. Antimicrob. Chemother., June 1, 2006; 57(6): 1100 - 1109. [Abstract] [Full Text] [PDF]

				K.-P. Leung, T.D. Crowe, J.J. Abercrombie, C.M. Molina, C.J. Bradshaw, C.L. Jensen, Q. Luo, and G.A. Thompson Control of Oral Biofilm Formation by an Antimicrobial Decapeptide J. Dent. Res., December 1, 2005; 84(12): 1172 - 1177. [Abstract] [Full Text] [PDF]

				S. P. Concannon, T. D. Crowe, J. J. Abercrombie, C. M. Molina, P. Hou, D. K. Sukumaran, P. A. Raj, and K. -P. Leung Susceptibility of oral bacteria to an antimicrobial decapeptide J. Med. Microbiol., December 1, 2003; 52(12): 1083 - 1093. [Abstract] [Full Text] [PDF]

				D. M. Rothstein, P. Spacciapoli, L. T. Tran, T. Xu, F. D. Roberts, M. Dalla Serra, D. K. Buxton, F. G. Oppenheim, and P. Friden Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5 Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1367 - 1373. [Abstract] [Full Text]

				M. Guggenheim, S. Shapiro, R. Gmür, and B. Guggenheim Spatial Arrangements and Associative Behavior of Species in an In Vitro Oral Biofilm Model Appl. Envir. Microbiol., March 1, 2001; 67(3): 1343 - 1350. [Abstract] [Full Text]